AlphaFold predicted structure
CYB5R3 · P00387

Mean pLDDT
93.9/ 100
Very high
301 residues
Confidence breakdown
- Very high(≥ 90)89%
- Confident(70–90)4%
- Low(50–70)4%
- Very low(< 50)3%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
cytochrome b5 reductase 3
Annotations refreshed 10 hours ago.
Diagnostic Grade (Green)
DDG2P
BIALLELIC, autosomal or pseudoautosomalIntellectual disability
BIALLELIC, autosomal or pseudoautosomalRare anaemia
BIALLELIC, autosomal or pseudoautosomalFetal anomalies
BIALLELIC, autosomal or pseudoautosomalRecessive hereditary methemoglobinemia type 1
Recessive hereditary methemoglobinemia type 2
methemoglobinemia due to deficiency of methemoglobin reductase
hereditary methemoglobinemia
central core myopathy
methemoglobinemia
Caffey disease
type 2 diabetes mellitus
hyperaldosteronism
musculoskeletal system disorder
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
NADH-cytochrome b5 reductase 3
Catalyzes the reduction of two molecules of cytochrome b5 using NADH as the electron donor
CYB5R3 · P00387

Mean pLDDT
93.9/ 100
Very high
301 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0